These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 26831665)

  • 41. Lymphovascular invasion in clear cell renal cell carcinoma--association with disease-free and cancer-specific survival.
    Belsante M; Darwish O; Youssef R; Bagrodia A; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    Urol Oncol; 2014 Jan; 32(1):30.e23-8. PubMed ID: 23428539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.
    Xu B; Zhang L; Luo C; Qi Y; Cui Y; Ying JM; Zhang Q; Jin J
    Int J Mol Sci; 2015 Jan; 16(1):1051-65. PubMed ID: 25569086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
    Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma.
    Glaser ZA; Love HD; Guo S; Gellert L; Chang SS; Herrell SD; Barocas DA; Penson DF; Cookson MS; Clark PE
    Urol Oncol; 2017 May; 35(5):286-293. PubMed ID: 28108243
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
    Zhao X; Zhao Z; Xu W; Hou J; Du X
    Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S100A8 Expression May Have a Prognostic Value in CCRCC Reflecting TNM Staging and Fuhrman Nuclear Grade.
    An HJ; Koh HM; Song DH
    Anticancer Res; 2019 Sep; 39(9):4681-4685. PubMed ID: 31519567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-30a-5p
    Outeiro-Pinho G; Barros-Silva D; Aznar E; Sousa AI; Vieira-Coimbra M; Oliveira J; Gonçalves CS; Costa BM; Junker K; Henrique R; Jerónimo C
    J Exp Clin Cancer Res; 2020 Jun; 39(1):98. PubMed ID: 32487203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival.
    Zhao J; Lu L
    Recent Pat Anticancer Drug Discov; 2021; 16(3):363-376. PubMed ID: 33563180
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
    Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
    Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.
    Pires-Luís AS; Costa-Pinheiro P; Ferreira MJ; Antunes L; Lobo F; Oliveira J; Henrique R; Jerónimo C
    J Transl Med; 2017 Jun; 15(1):149. PubMed ID: 28662726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GATA5 CpG island hypermethylation is an independent predictor for poor clinical outcome in renal cell carcinoma.
    Peters I; Gebauer K; Dubrowinskaja N; Atschekzei F; Kramer MW; Hennenlotter J; Tezval H; Abbas M; Scherer R; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    Oncol Rep; 2014 Apr; 31(4):1523-30. PubMed ID: 24549248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma.
    La Rochelle J; Klatte T; Dastane A; Rao N; Seligson D; Said J; Shuch B; Zomorodian N; Kabbinavar F; Belldegrun A; Pantuck AJ
    Cancer; 2010 Oct; 116(20):4696-702. PubMed ID: 20629029
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.
    van Vlodrop IJ; Baldewijns MM; Smits KM; Schouten LJ; van Neste L; van Criekinge W; van Poppel H; Lerut E; Schuebel KE; Ahuja N; Herman JG; de Bruïne AP; van Engeland M
    Am J Pathol; 2010 Feb; 176(2):575-84. PubMed ID: 20042676
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
    Malouf GG; Su X; Zhang J; Creighton CJ; Ho TH; Lu Y; Raynal NJ; Karam JA; Tamboli P; Allanick F; Mouawad R; Spano JP; Khayat D; Wood CG; Jelinek J; Tannir NM
    Clin Cancer Res; 2016 Dec; 22(24):6236-6246. PubMed ID: 27256309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity.
    Dong K; Chen W; Pan X; Wang H; Sun Y; Qian C; Chen W; Wang C; Yang F; Cui X
    BMC Cancer; 2022 Feb; 22(1):140. PubMed ID: 35120484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.
    Wuttig D; Zastrow S; Füssel S; Toma MI; Meinhardt M; Kalman K; Junker K; Sanjmyatav J; Boll K; Hackermüller J; Rolle A; Grimm MO; Wirth MP
    Int J Cancer; 2012 Sep; 131(5):E693-704. PubMed ID: 22213152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.